Clinical Trial Update: COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF

View source ↗

Summary

A completed clinical trial evaluating antibody responses to COVID-19 in people with cystic fibrosis (CAR-CF), sponsored by Medical University Innsbruck.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Medical University Innsbruck | Conditions: Cystic Fibrosis, Covid19 | Status: COMPLETED